Retinal Pigment Epithelial Cell Line with Fast Differentiation and Improved Barrier Properties.
Ontology highlight
ABSTRACT: Retinal pigment epithelium (RPE) acts as an outer blood-retinal barrier that limits the access of circulating xenobiotics to the eye. In addition, the RPE limits posterior elimination of intravitreally injected drugs to circulation. Thus, permeation in the RPE has a significant effect on ocular pharmacokinetics. The RPE is also a potentially important drug target in age-related macular degeneration. Therefore, the cell models of the RPE are important tools in ocular drug development, but poor availability and problems in reproducibility limit the use of primary RPE cell cultures. Furthermore, the best and widely used human cell line ARPE19 requires specialized culture conditions and a long time for cellular differentiation. In this paper, we describe a cell population arisen from the ARPE1
SUBMITTER: Hellinen L
PROVIDER: S-EPMC6722654 | biostudies-literature | 2019 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA